Browsing All Posts By Kurt Osterberg
-
Finance 0
Time To Buy SEK, RUB And MXN? Our Indicators Say So
Today we have published the August edition of Global Monetary Condition Monitor our monthly flagship publication, which covers monetary policy in 26 countries around the world and gives an overview ... -
Finance 0
Nuvectra Corporation – Sold
64% technical sell signals Below its 20, 50 and 100 day moving averages 29.40% off its recent high This morning I deleted Nuvectra (NVTR) from the Van Meerten New High portfolio at 10.55 It is not... -
Finance 0
Has USD/CAD Reversed?
With oil prices continuing to drift lower and with Canadian inflation subdued USD/CAD made a major reversal in US trade today recovering above the 1.2550 level as longs pressed the pair higher. Wit... -
Finance 0
July 2017 Leading Index Review: Growth Trends Slow
This post is a review of all major leading indicators follows – and their trends are generally indicating slower growth. Philly Fed Leading Index The Philly Fed Leading Index for the United Sta... -
Finance 0
Portfolio Management Ideas For Consideration For The Remainder Of 2017
2017 is shaping up to be both a continuation of the secular bull market as well as a year of changing market leadership. This has taken place absent any significant market volatility, leading some to ... -
Finance 0
New Peak In Household Debt And Gold
In August, the New York Fed released a new update on household debt today showing record levels. What does it imply for the gold market? On surface, the report about the household debt is scary, as ... -
Finance 0
Trump’s Decision To Deploy Troops Will Boost Gas Prices
In a nationally televised speech, President Donald Trump announced his decision to raise gas prices. Most analysts missed that part of the speech. They only heard the part about increasing the number ... -
Finance 0
…And The Market Breaks
Having melted up on a sea of momentum since the US open, the stock market just broke… At 1322ET, BATS declared self-help against Chicago Stock Exchange… And VIX and Nasdaq reacted… A... -
Finance 0
Anthera’s Blisibimod Positive In Phase II Extension Study
Anthera Pharmaceuticals, Inc. (ANTH – Free Report) announced positive top-line data from the extension of a phase II BRIGHT-SC study, evaluating key pipeline candidate, blisibimod for treatme...
Top Posts
-
The Importance for Individuals to Use Sustainable Chemicals
-
Small Businesses: Finding the Right Candidate for the Job
-
How to Write the Perfect Thank You Letter After Your Job Interview
-
3 Best Large-Cap Blend Mutual Funds For Enticing Returns
-
China suspected in massive breach of federal personnel data
